Hoffmann, Jochen H.O., et al. “Routine Laboratory Parameter Dynamics and Laboratory Adverse Events in Psoriasis Patients on Long-Term Treatment With Adalimumab, Etanercept, and Ustekinumab”. Acta Dermato-Venereologica, vol. 97, no. 6, Mar. 2017, pp. 705-10, doi:10.2340/00015555-2644.